THY1 and rheumatoid arthritis: Wei et al. found that in active RA, the expression levels of NOTCH3 and NOTCH target genes were significantly upregulated in synovial CD90+ fibroblasts, and that genetic deletion of NOTCH3 or monoclonal antibody blockade of NOTCH3 signaling attenuated inflammation and prevented joint damage in inflammatory arthritis.